Topical / inhaled corticosteroid
Mometasone furoate
Brand names: Asmanex, Nasonex, Elocon
Adult dose
Dose: Asthma inhaled: 200–400 micrograms BD. Nasal spray: 2 sprays each nostril OD. Topical (Elocon): apply OD
Route: Inhaled/Nasal/Topical
Frequency: OD-BD
Clinical pearls
- Asthma maintenance, allergic rhinitis, eczema/psoriasis
- Rinse mouth after inhaled use
Contraindications
- Untreated infection (topical)
- Local sensitivity
Side effects
- Oral candidiasis (inhaled)
- Hoarseness
- Epistaxis (nasal)
- Skin atrophy (topical)
- Adrenal suppression at high dose
Interactions
- Strong CYP3A4 inhibitors (ritonavir/ketoconazole — Cushing's)
Monitoring
- Symptom control
- Growth (children)
Reference: BNF; BTS/SIGN; NICE NG80/NG222; https://bnf.nice.org.uk/drugs/mometasone-furoate/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024